✦ LIBER ✦

Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer

✍ Scribed by Carlos H. Barrios; Mei-Ching Liu; Soo Chin Lee; Laurence Vanlemmens; Jean-Marc Ferrero; Toshio Tabei; Xavier Pivot; Hiroji Iwata; Kenjiro Aogi; Roberto Lugo-Quintana; Nadia Harbeck; Marla J. Brickman; Ke Zhang; Kenneth A. Kern; Miguel Martin

Publisher: Springer US
Year: 2010
Tongue: English
Weight: 289 KB
Volume: 121
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-010-0788-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized phase-III trial of docetaxe

A randomized phase-III trial of docetaxel/capecitabine versus doxorubicin/cyclophosphamide as primary chemotherapy for patients with stage II/III breast cancer

✍ Keun Seok Lee; Jungsil Ro; Byung-Ho Nam; Eun Sook Lee; Youngmee Kwon; Hye Soo Kw 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 285 KB

Phase I trial of capecitabine plus evero

Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer

✍ Taekyu Lim; Jeeyun Lee; Duk Joo Lee; Ha Yeon Lee; Boram Han; Kyung Kee Baek; Hee 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 313 KB

Multicenter phase II randomized trial ev

Multicenter phase II randomized trial evaluating antiangiogenic therapy with sunitinib as consolidation after objective response to taxane chemotherapy in women with HER2-negative metastatic breast cancer

✍ H. Wildiers; C. Fontaine; P. Vuylsteke; M. Martens; J. L. Canon; W. Wynendaele; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 203 KB

Randomized Phase II Trial of weekly pacl

Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer

✍ Giampietro Gasparini; Massimo Gion; Luigi Mariani; Paola Papaldo; Diana Crivella 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 222 KB

A phase III randomized comparison of lap

A phase III randomized comparison of lapatinib plus capecitabine versus capecitabine alone in women with advanced breast cancer that has progressed on trastuzumab: updated efficacy and biomarker analyses

✍ David Cameron; Michelle Casey; Michael Press; Deborah Lindquist; Tadeusz Pienkow 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 330 KB

Phase II, double-blind, randomized trial

Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy

✍ Mark Clemons; Anil A. Joy; Radhi Abdulnabi; Mauricio Kotliar; Jodi Lynch; Johan 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 317 KB